Viewing Study NCT04996160


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-27 @ 10:57 AM
Study NCT ID: NCT04996160
Status: RECRUITING
Last Update Posted: 2025-01-24
First Post: 2021-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
Sponsor: Tanja Andrea Gruber
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module